dc.date.accessioned |
2020-10-21T06:46:25Z |
|
dc.date.available |
2020-10-21T06:46:25Z |
|
dc.date.issued |
2019 |
|
dc.date.issued |
2019/07/27 |
|
dc.identifier.citation |
,,.Drugs Today (Barc). 2019 Jul;55(7):459-467. doi: 10.1358/dot.2019.55.7.3015642. |
|
dc.identifier.uri |
http://doi.org/10.1358/dot.2019.55.7.3015642 |
|
dc.identifier.uri |
https://hdl.handle.net/20.500.12619/71856 |
|
dc.description |
PMID = 31347614 |
|
dc.relation.isversionof |
10.1358/dot.2019.55.7.3015642 |
|
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.title |
Talazoparib to treat BRCA-positive breast cancer |
|
dc.type |
article |
|
dc.relation.journal |
Drugs Today (Barc) |
|
dc.identifier.doi |
10.1358/dot.2019.55.7.3015642 |
|
dc.contributor.author |
Guney Eskiler G. |
|
dc.relation.publicationcategory |
Makale - Uluslararası Hakemli Dergi |
|